177 related articles for article (PubMed ID: 26166219)
21. Clinicopathologic and cytogenetic characterization of therapy-related acute T lymphoblastic leukemia in adult population.
Parekh V; Peker D
Leuk Lymphoma; 2016; 57(6):1460-2. PubMed ID: 26585442
[No Abstract] [Full Text] [Related]
22. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.
Saygin C; Kishtagari A; Cassaday RD; Reizine N; Yurkiewicz I; Liedtke M; Stock W; Larson RA; Levine RL; Tallman MS; Park JH; Kerr C; Przychodzen B; Sekeres MA; Kalaycio ME; Carraway HE; Hamilton BK; Sobecks R; Gerds A; Mukherjee S; Nazha A; Maciejewski JP; Advani AS
Blood Adv; 2019 Dec; 3(24):4228-4237. PubMed ID: 31869410
[TBL] [Abstract][Full Text] [Related]
23. Acute leukemia of plasmablastic type as terminal phase of multiple myeloma.
Piccinini L; Artusi T; Bonacorsi G; Arigliano V
Haematologica; 2002 Feb; 87(2):EIM04. PubMed ID: 11836178
[No Abstract] [Full Text] [Related]
24. Translocation (1;3)(p36;q21) in secondary leukemia.
Panani AD; Ferti-Passantonopoulou A; Economopoulos T; Raptis S
Cancer Genet Cytogenet; 1990 Nov; 50(1):165-7. PubMed ID: 2253185
[TBL] [Abstract][Full Text] [Related]
25. Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy.
Pagano L; Pulsoni A; Mele L; Leone G
Leuk Lymphoma; 2000 Nov; 39(5-6):465-75. PubMed ID: 11342330
[TBL] [Abstract][Full Text] [Related]
26. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
Dunphy CH; Kitchen S; Saravia O; Velasquez WS
Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944
[TBL] [Abstract][Full Text] [Related]
27. Philadelphia chromosome as a recurrent event among therapy-related acute leukemia.
Aldoss I; Stiller T; Song J; Al Malki M; Ali H; Salhotra A; Aribi A; Khaled S; Gaytan P; Murata-Collins J; Palmer J; Snyder D; O'Donnell M; Nakamura R; Stein AS; Forman SJ; Marcucci G; Pullarkat V
Am J Hematol; 2017 Feb; 92(2):E18-E19. PubMed ID: 27862221
[No Abstract] [Full Text] [Related]
28. Precursor B lymphoblastic leukemia 32 months after local therapy for a primary extramedullary myeloid cell tumor.
Szinnai G; Cogliatti SB; Avoledo P; Dirnhofer S; Schmid U; Kühne T
Pediatr Blood Cancer; 2007 Dec; 49(7):1039-46. PubMed ID: 16572408
[TBL] [Abstract][Full Text] [Related]
29. Kappa light chain myeloma with initial cutaneous involvement.
Saka B; Erten N; Oztürk G; Yilmaz C; Dogan O; Buyukbabani N; Besisik SK
Ann Hematol; 2006 Apr; 85(4):272-4. PubMed ID: 16425024
[No Abstract] [Full Text] [Related]
30. Liquid tumors in the elderly.
Mato A; Feldman T; Richter J; Siegel DS; Goy A
Clin Geriatr Med; 2012 Feb; 28(1):115-52. PubMed ID: 22326039
[No Abstract] [Full Text] [Related]
31. Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma.
Aldoss I; Capelletti M; Park J; Pistofidis RS; Pillai R; Stiller T; Sanchez JF; Forman SJ; Ghobrial IM; Krishnan A
Leukemia; 2019 Jan; 33(1):266-270. PubMed ID: 30026571
[TBL] [Abstract][Full Text] [Related]
32. [B-cell acute lymphoblastic leukemia developed 5 years after autologous stem cell transplantation for multiple myeloma].
Tsukada Y; Hattori Y; Nakajima H; Yokoyama K; Murata M; Shimizu N; Kondo N; Okamoto S
Rinsho Ketsueki; 2012 Feb; 53(2):219-23. PubMed ID: 22450582
[TBL] [Abstract][Full Text] [Related]
33. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
Kaya H; Nakamura S; Yamazaki H; Kumabashiri I; Ohtake S; Matsuda T
Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597
[TBL] [Abstract][Full Text] [Related]
34. Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
Innes A; May PC; Pavlů J; Bain BJ
Am J Hematol; 2012 Apr; 87(4):412. PubMed ID: 21953481
[No Abstract] [Full Text] [Related]
35. Relapse of aggressive myeloma after complete remission in secondary acute leukemia: coincidence or consequence?
Bairey OS; Sandbank Y; Shaklai M
Leuk Lymphoma; 1993 Dec; 12(1-2):147-51. PubMed ID: 8161931
[TBL] [Abstract][Full Text] [Related]
36. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
[No Abstract] [Full Text] [Related]
37. B cell malignancies presenting with unusual bone involvement and mimicking multiple myeloma. Study of nine cases.
Rossi JF; Bataille R; Chappard D; Alexandre C; Janbon C
Am J Med; 1987 Jul; 83(1):10-6. PubMed ID: 3496790
[TBL] [Abstract][Full Text] [Related]
38. Third biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
[No Abstract] [Full Text] [Related]
39. [Mucoepidermoid carcinoma of the parotid gland as a secondary malignancy developed ten years after chemotherapy for childhood acute lymphoblastic leukemia].
Miyatima Y; Ogawa A; Kuno K; Toda K; Suzuki K; Mituya A
Rinsho Ketsueki; 2007 Jun; 48(6):491-4. PubMed ID: 17633097
[TBL] [Abstract][Full Text] [Related]
40. An Unconventional Presentation of Multiple Myeloma: Bazex Syndrome.
Kandemir Alibakan Ö; Demirel N; Nizam N; Eren R
Turk J Haematol; 2020 Nov; 37(4):294-296. PubMed ID: 32830932
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
